Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSPPC-96 in resectable NSCLC
NCT00098085Phase 2Completed
- Sponsor
- Agenus Inc.
- Start
- Sep 2003
- Primary completion
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of vitespen in non-small cell lung cancer (NSCLC), sponsored by Agenus Inc.. Started Sep 2003; status: completed.
02
Drugs
vitespen
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00098085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00098085.